Clinical Trials Logo
  1. Home
  2. Other
  3. NCT03766035

Cholangioscopy in Primary Sclerosing Cholangitis (PSC)

Primary Sclerosing Cholangitis (PSC) Clinical Trial

Official title:
Cholangioscopy in Primary Sclerosing Cholangitis (PSC)

Clinical Trial Summary

To demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard endoscopic retrograde cholangiopancreatography (ERCP) with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC).

Clinical Trial Description

The primary objective of this study is to demonstrate the clinical utility of the addition of per oral cholangioscopy (POCS) to standard ERCP with brushing cytology for diagnosis and early detection of cholangiocarcinoma in patients diagnosed with primary sclerosing cholangitis (PSC). ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03766035
Study type Observational
Source Boston Scientific Corporation
Contact
Status Completed
Phase
Start date December 6, 2018
Completion date December 12, 2022
View Details
See also
  Status Clinical Trial Phase
Completed NCT05082779 - Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CS0159 Phase 1
Completed NCT06037577 - Subcutaneous Doses of CM-101 as a Treatment for Medical Conditions Involving Inflammatory and Fibrotic Mechanisms in Healthy Male Subjects Phase 1
Completed NCT01672853 - Simtuzumab (GS-6624) in the Prevention of Progression of Liver Fibrosis in Adults With Primary Sclerosing Cholangitis (PSC) Phase 2
Completed NCT02061540 - Open Label Study to Evaluate Safety and Efficacy of LUM001 in Patients With Primary Sclerosing Cholangitis Phase 2
Completed NCT01819766 - Detection of Advanced Colorectal Neoplasia by Stool DNA in Inflammatory Bowel Disease N/A
Active, not recruiting NCT01161992 - Genomics of Primary Sclerosing Cholangitis (PSC)
Completed NCT02808312 - Pharmacokinetics and Pharmacodynamics of Cilofexor in Adults With Normal and Impaired Hepatic Function Phase 1
Completed NCT03333928 - A POC and Dose-Ranging Study of HTD1801 in PSC Patients Phase 2
Completed NCT02177136 - Obeticholic Acid (OCA) in Primary Sclerosing Cholangitis (PSC) Phase 2
Completed NCT01695174 - A Pilot Study of Xifaxan to Treat Patients With PSC Phase 1
Recruiting NCT06026865 - S-adenosylmethionine (SAMe) in Patients With Primary Sclerosing Cholangitis (PSC) N/A